Picture of Neuren Pharmaceuticals logo

NEU Neuren Pharmaceuticals Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Neuren Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-0.879-0.7250.819-1.230.081
Other Operating Cash Flow
Cash from Operating Activities-11.7-8.08-9.973.6185
Capital Expenditures-0.012-0.006-0.01-0.019-0.04
Purchase of Fixed Assets
Other Investing Cash Flow Items-211
Purchase of Investments
Cash from Investing Activities-0.012-0.006-0.01-0.019-211
Financing Cash Flow Items1.86-1.07-1.11-0.002-0.018
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities1.8619.122.2-0.0023.62
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-9.7310.312.63.4-23.1